Human Metabolome Technologies, Inc. provided consolidated earnings guidance for the full year ending June 30, 2021. For the full year, the company expects net sales to be JPY 1,200 million, operating profit to be JPY 20 million, profit attributable to owners of parent to be JPY 10 million and basic earnings per share to be JPY 1.69.